applsci-logo

Journal Browser

Journal Browser

Clinical Application of Lipid-Based Nanocarriers: Is There a Chance?

A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Nanotechnology and Applied Nanosciences".

Deadline for manuscript submissions: closed (31 January 2020) | Viewed by 158

Special Issue Editor


E-Mail Website
Guest Editor
Department of Drug Sciences and Health, University of Catania, 95125 Catania, Italy
Interests: drug delivery systems; nanoparticulate lipid matrix systems; nanocarriers for the transport of active molecules
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Recently, various nanotechnology platforms in the area of medical biology and therapies have gained remarkable attention. Moreover, research and development of engineered multifunctional nanoparticles as pharmaceutical drug carriers have spurred the exponential growth of applications in medicine during the last decade. Design principles of these nanoparticles—including nanoemulsions, dendrimers, nanogold, liposomes, drug–carrier conjugates, antibody–drug complexes, and magnetic nanoparticles—are primarily based on the unique assemblies of synthetic, natural, or biological components, including but not limited to synthetic polymers, metal ions, oils, and lipids as building blocks. It is a fact that the potential success of these systems in the clinic is dependent on the consideration of important parameters such as formulation strategies, their physical properties, drug-loading efficiencies, drug release potential and, most importantly, minimal toxicity of the carrier itself.

The Special Issue of the journal Applied SciencesClinical Application of Lipid-Based Nanocarriers: Is There a Chance?” will cover recent advances in the development of lipid-based nanocarriers, highlighting the efforts of researchers in concretizing the clinical application of these innovative systems.

Prof. Dr. Carmelo Puglia
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • colloidal drug delivery systems (CDDS)
  • nanostructured lipid carriers (NLC)
  • solid lipid nanoparticles (SLN)
  • drug delivery
  • prolonged release
  • controlled release
  • drug targeting
  • improved drug bioavailability
  • main administration routes

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop